Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Caribou Biosciences, Inc. (CRBU)

Corbus Pharmaceuticals Holdings, Inc. and Caribou Biosciences, Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Caribou Biosciences, Inc. are of similar size ($144.1M and $134.0M). Caribou Biosciences, Inc. grew revenue faster over the last twelve months: 10.0% against −73.7%. Corbus Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −1,030.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Caribou Biosciences, Inc. leads on 12 and Corbus Pharmaceuticals Holdings, Inc. on 4.

Valuation

Metric CRBP CRBU Biotechnology median
P/E n/m n/m 7.88
P/S 89.99 12.58 11.47
P/B 1.36 1.29 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 22.77 1.39 10.73
Earnings yield (86.69%) (86.40%) (28.84%)
Free cash flow yield (62.56%) (105.20%) (23.03%)

Profitability

Metric CRBP CRBU Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,090.90%) 0.00%
Net margin 0.00% (1,030.42%) 0.00%
Free cash flow margin 0.00% (1,323.30%) 0.00%
Return on equity (95.58%) (78.27%) (57.72%)
Return on assets (80.85%) (56.87%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP CRBU Biotechnology median
Revenue growth (TTM) (73.69%) 10.02% 5.64%
EPS growth (last fiscal year) (60.33%) 3.64% —
Revenue growth, 5-year CAGR (14.34%) (2.03%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP CRBU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 6.49 4.73
Net debt to EBITDA 1.90 0.96 0.96

Dividend

Metric CRBP CRBU Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CRBP CRBU Biotechnology median
Market cap 144.09m 134.01m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack